2011
DOI: 10.1016/j.hrthm.2011.02.021
|View full text |Cite
|
Sign up to set email alerts
|

Transient outward current (Ito) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome

Abstract: Background Brugada syndrome (BrS) is a sudden death predisposing genetic condition characterized electrocardiographically by ST-segment elevation in the leads V1-V3. Given the prominent role of the transient outward current (Ito) in BrS pathogenesis, we hypothesized that rare gain-of-function mutations in KCND3 may serve as a pathogenic substrate for BrS. Methods Comprehensive mutational analysis of KCND3-encoded Kv4.3 (Ito) was conducted using PCR, DHPLC, and direct sequencing of DNA derived from 86 unrelat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
173
0
1

Year Published

2011
2011
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 228 publications
(183 citation statements)
references
References 25 publications
9
173
0
1
Order By: Relevance
“…62 Gain-of-function pathogenic variants in the KCND3-encoded K v 4.3 potassium channel are implicated in the pathogenesis and phenotypic expression of BrS, inducing lethal arrhythmia that has been precipitated by a genetically enhanced I to current gradient within the right ventricle. 63 Interestingly, the KCNE5 gene is located on the X chromosome, adding a new pattern of inheritance for BrS. 64 Hence, pathogenic variations in KCNE5 cause a gain-of-function effect on I to current gradients.…”
Section: Genetic Basismentioning
confidence: 99%
“…62 Gain-of-function pathogenic variants in the KCND3-encoded K v 4.3 potassium channel are implicated in the pathogenesis and phenotypic expression of BrS, inducing lethal arrhythmia that has been precipitated by a genetically enhanced I to current gradient within the right ventricle. 63 Interestingly, the KCNE5 gene is located on the X chromosome, adding a new pattern of inheritance for BrS. 64 Hence, pathogenic variations in KCNE5 cause a gain-of-function effect on I to current gradients.…”
Section: Genetic Basismentioning
confidence: 99%
“…9,14 Mutations in glycerol-3-phophate dehydrogenase 1-like enzyme gene (GPD1L, BrS2), SCN1B (β1-subunit of Na channel, BrS5), KCNE3 (MiRP2; BrS6), SCN3B (β3-subunit of Na channel, BrS7), KCNJ8 (BrS8), and KCND3 (BrS10) are more rare. [10][11][12]15,16,34 These genetic defects cause a loss of function of I Na or I Ca , or a gain of function of I to . These and other genetic variants may give rise to subclinical forms of BrS, that can predispose to acquired forms of BrS developing following administration of antidepressants such as amitriptyline and pharmacological agents with similar actions.…”
Section: Discussionmentioning
confidence: 99%
“…Mutations leading to loss of function in I Na and I Ca , as well as those giving rise to a gain of function in I to , have been identified as genetic causes of BrS. [6][7][8][9][10][11][12][13][14][15][16][17] BrS has thus far been associated with mutations in 11 different genes.…”
Section: Introductionmentioning
confidence: 99%
“…Pathogenic mutations in this gene have been associated with LQTS, SIDS, AF and BrS (Figure 2). In 2011, Giudicessi et al [47] provide the first molecular and functional evidence implicating novel KCND3 gain-of-function mutations (Kir4.3 protein) in the pathogenesis and phenotypic expression of BrS, with enhanced I to current gradient within the right ventricle where the KCND3 gene expression is the highest. Currently, two pathogenic mutations have been associated with BrS, p.Leu450Phe (c.1348C>T, p.L450F) (CM111334), and p.Gly600Arg (c.1798G>C, p.G600R) (CM1110945) [48] despite this last variation was reported in a SUDS case with no confirmed BrS, so far.…”
Section: Kcnd3mentioning
confidence: 99%